Oenon HoldingsOenon Holdings, Inc.2533東証プライム食料品FY ending Dec 2025, consolidated, J-GAAP
About 94% of Oenon Holdings's sales come from Liquor, with Enzymatic medicine and Real estate making up much of the rest.
Out of every ¥100 of sales, about ¥4 is left as operating profit.
Revenue changed -1.0% from the prior year, operating profit -3.8%.
Revenue -1.0% · profit -3.8%, calculated from disclosed figures.
Operating leverage: 3.85× (profit growth ÷ revenue growth)
FY ending Dec 2023 → FY ending Dec 2024
FY ending Dec 2023 → FY ending Dec 2024
For every ¥100 Oenon Holdings sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書-第119期(2025/01/01-2025/12/31)
EDINET (FSA Japan)
有価証券報告書-第118期(2024/01/01-2024/12/31)
EDINET (FSA Japan)
有価証券報告書-第117期(2023/01/01-2023/12/31)
EDINET (FSA Japan)
有価証券報告書-第116期(2022/01/01-2022/12/31)
EDINET (FSA Japan)
有価証券報告書-第115期(令和3年1月1日-令和3年12月31日)
EDINET (FSA Japan)
有価証券報告書-第114期(令和2年1月1日-令和2年12月31日)
Extracted from XBRL: 55 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.